Skip to main content

Outcomes and Prognostic Factors for Malawian Women with Breast Cancer

April 10, 2020

April 2020 – Breast cancer incidence in sub-Saharan Africa is increasing, and the region has the highest age-standardized breast cancer mortality rate worldwide. In a setting where breast cancer data are limited, our findings indicate that late stage presentation, HER2-enriched and triple-negative subtypes, and HIV coinfection were associated with mortality and were more prevalent in … Continued

Modified EPOCH for High-Risk Non-Hodgkin Lymphoma in Sub-Saharan Africa

January 10, 2020

January 2020 – Aggressive NHL is among the most common cancers in SSA where CHOP is the standard treatment and outcomes are poor. We treated patients with a modified EPOCH regimen with moderate outcomes. Results indicate that this regimen was feasible and effective in a small cohort and suggest EPOCH with setting-appropriate modifications may be … Continued

Fogarty Awards Two of Five U.S. International Research Scientist Development Awards to Malawi Cancer Program Faculty

October 17, 2019

To bolster promising global health research careers, Fogarty and its partners are awarding up to $9.9 million over five years through two career development programs. The grants will help ensure that advanced postdoctoral scientists and junior faculty have a pathway to independence, with protected time for research activities under the guidance of experienced mentors in … Continued

Facilitators and Barriers to Traditional Medicine Use Among Malawian Cancer Patients

October 10, 2019

October 2019 – Increasing access to conventional cancer treatment in low-income countries is an important public health initiative to address the global burden of cancer. Our findings indicate that cancer patients in our cohort rely on a pragmatic and experience-based treatment selection process and provide insights to the various factors that influence T&CM use among cancer … Continued

Microcosting Analysis of Diffuse Large B-Cell Lymphoma Treatment in Malawi

July 11, 2019

July 2019 – Cost analysis of treating diffuse large B-cell lymphoma (DLBCL) in Malawi indicates that per-patient cost of first-line treatment of DLBCL in Malawi is low relative to high-income countries, suggesting that investments in fixed-duration, curative-intent DLBCL treatment may be attractive in sub-Saharan Africa.

Global Oncology

July 11, 2019

June 2019 – This article highlights the important role of cancer care and research outside the United States, particularly in low- and middle-income countries, in furthering innovative solutions for cancer that can be applied worldwide.

Epidemiological and Histopathological Profile of Malignant Melanoma in Malawi

April 10, 2019

April 2019 – Studies on malignant melanoma have largely focused on Caucasian populations with very limited data on the disease in black Africans. This retrospective study characterizes melanoma cases in Lilongwe, Malawi and demonstrates that malignant melanoma occurs in black Malawians and may be an under-appreciated malignancy.